IP Library Granted Patent US 7,902,121
Granted Patent B2
US 7,902,121 · App. 10/856,185 · Granted Mar 8, 2011

MHC-antigen arrays for detection and characterization of immune responses

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,902,121
App. No.
10/856,185
Granted
Mar 8, 2011
Kind
B2
Abstract

T cells are profiled with respect to their expression of antigen receptor. The cells are arrayed on a planar or three-dimensional substrate through binding to immobilized or partially diffused MHC-antigen complexes. The cells may further be characterized with respect to their ability to respond to external stimulus in the microenvironment. External stimuli include cell-cell interactions, response to factors, and the like.

Claims (36)

1. A method of profiling T cells, the method comprising:

contacting a cell population comprising T cells with an array, wherein said array comprises multiple discrete regions of MHC-antigen complexes stably associated with the surface of a solid planar support, and wherein an MHC-antigen complex comprises monomers or multimers of an α MHC subunit, a β MHC subunit, and a peptide antigen bound in the cleft formed by the α and β subunits;

binding T cells to the MHC antigen complexes and

analyzing T cells bound to the array by evaluating phenotypic attributes.

2. The method according to claim 1 , wherein said array comprises a plurality of different MHC-antigen complexes.

3. A method of profiling T cells, the method comprising:

contacting a cell population comprising T cells with an array, wherein said array comprises multiple discrete regions of MHC-antigen complexes stably associated with the surface of a solid planar support coated with polyacrylamide, and wherein an MHC-antigen complex comprises monomers or multimers of an α MHC subunit, a β MHC subunit, and a peptide antigen bound in the cleft formed by the α and β subunits;

binding T cells to the MHC antigen complexes and

analyzing T cells bound to the array by evaluating phenotypic attributes.

4. The method according to claim 1 , wherein each of said regions comprises at least about 0.01 ng of said MHC-antigen complex.

5. The method according to claim 1 , wherein each of said regions comprises a plurality of different antigenic complexes.

6. The method according to claim 1 , wherein one or more of said MHC-antigen complexes comprises an antigen selected from the group consisting of tumor antigens; viral antigens, bacterial antigens; parasitic antigens; environmental antigens; allergens; and autoimmune antigens.

7. The method according to claim 1 , wherein said cell population comprises multiple T cell antigenic specificities.

8. The method according to claim 1 , wherein said cell population comprises multiple cell types.

9. The method according to claim 1 , wherein said cell population is selected from the group consisting of blood, lymph, cerebrospinal fluid and synovial fluid.

10. The method according to claim 9 , wherein said T cells are labeled with a detectable marker prior to said contacting step, and wherein said analyzing detects the presence of said marker.

11. The method according to claim 1 , wherein said MHC-antigen complexes comprise a library of antigenic peptides complexed with MHC.

12. A method of profiling T cells, the method comprising:

contacting a cell population comprising T cells with an array, wherein said array comprises multiple discrete regions of MHC-antigen complexes stably associated with the surface of a solid planar support, and wherein an MHC-antigen complex comprises monomers or multimers of an α MHC subunit, a β MHC subunit, and a peptide antigen bound in the cleft formed by the α and β subunits;

binding T cells to the MHC antigen complexes and

analyzing T cells bound to the array by determining a change in phenotype of said T cells after contacting with said array.

13. The method according to claim 12 , wherein said change in phenotype comprises secretion of a protein in response to antigenic stimulation.

14. A method of profiling T cells the method comprising:

contacting a cell population comprising T cells with an array, wherein said array comprises multiple discrete regions of MHC-antigen complexes stably associated with the surface of a solid planar support, wherein one or more of said discrete regions present on said array comprise cells and MHC-antigen complexes, and wherein an MHC-antigen complex comprises monomers or multimers of an α MHC subunit, a β MHC subunit, and a peptide antigen bound in the cleft formed by the α and β subunits;

binding T cells to the MHC antigen complexes and

analyzing T cells bound to the array by evaluating phenotypic attributes.

15. The method according to claim 14 , wherein said cells are antigen presenting cells.

16. The method according to claim 1 , further comprising the step of contacting said array with a second cell population, and determining the binding of cells present in said second cell population to said T cells bound to the array.

17. The method according to claim 1 , further comprising the step of contacting said array with a second cell population, and determining a change in the phenotype of said T cells bound to the array.

18. The method of claim 1 , further comprising the step of determining the expression of cell surface antigens by said T cells following said contacting step.

19. The method according to claim 1 , further comprising the step of releasing said cells from said array.

20. The method according to claim 1 , further comprising the step of expanding said T cells following said contacting step.

21. The method according to claim 20 , wherein said expanding step comprises contacting said T cells with one or more of growth factors, cytokines, cell adhesion molecules, and extracellular matrix material.

22. The method according to claim 1 , wherein said array comprises a plurality of spots having differing concentrations of MHC-antigen complexes.

23. The method according to claim 22 , further comprising the step of constructing a scaling curve for binding of T cells to said MHC-antigen complexes.

24. The method according to claim 1 , further comprising the step of determining binding of said cells to said MHC antigen complexes in a site specific analysis.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 23, 2013
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030486/0828 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2004
From: HOWARD HUGHES MEDICAL INSTITUTE
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 015191/0714 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2004
From: CHEN, DANIEL SHIN-YU; SOEN, YOAV; KRAFT, DANIEL LEWIS
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 015191/0723 →
Continuity (4)
Continuation In Part 10190425 · Jul 2, 2002
Provisional Application 60303109 · Jul 2, 2001
Provisional Application 60473936 · May 27, 2003
Related Publication 20050019843A1 · Jan 27, 2005